Home / Biosimilars
Biosimilars
News![]() In March 2021, Formycon confirmed the resubmission strategy for their Lucentis® (ranibizumab) biosimilar candidate (FYB2010)... ![]() US-based Coherus BioSciences (Coherus) announced on 17 February 2021 that the US Food and Drug Administration (FDA) had accep... ![]() Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), has approved a teriparatide biosimilar and th... ![]() The Argentina-based Richmond Laboratory (Laboratorios Richmond) announced on 19 March 2021 that it had gained approval from A... ![]() The European Commission (EC) has granted marketing authorization for the insulin aspart biosimilar Kixelle (MYL 1601D), devel... |
Research![]() What patient, physician and practice characteristics are associated with biosimilar usage for the biologicals filgrastim and... ![]() A recent paper by Spanish dermatologists reviews the principles of biosimilarity and equivalence trials that have led to the... ![]() Fujifilm Kyowa Kirin Biologics’ adalimumab biosimilar FKB327 has been found to cause less injection-site pain compared to the... ![]() Compared to chemical drugs, biologicals are more expensive because of their complicated manufacturing processes. Patients oft... ![]() A study of an injection pen formulation of the etanercept biosimilar YLB113, which is manufactured by the Japanese firm YL Bi... |
General![]() British Columbia (BC), the first province in Canada to switch patients to biosimilar drugs, has added adalimumab to its switc... ![]() Ustekinumab is a humanized monoclonal antibody that interferes with the triggering of the body’s inflammatory response throug... ![]() Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor. It is indicated for the treatment of neovascular (wet)... ![]() Last update: 2 April 2021In China, the regulatory body for the approval of medicines, including biologicals, is the National... ![]() Last update: 26 March 2021In South Korea, the regulatory body for the approval of medicines, including biologicals and b... |
Generics News Research General
- US$1.2 FDA contract for generic drug computatio...Generics/General | Posted 16/04/2021
- Dispensing branded drugs costs Medicare over a...Generics/Research | Posted 09/04/2021
- Technological approaches to drug repurposing fo...Generics/Research | Posted 02/04/2021
- EMA recommends approval of abiraterone and thio...Generics/News | Posted 02/04/2021
Biosimilars News Research General
- Characteristics associated with biosimilar use...Biosimilars/Research | Posted 16/04/2021
- British Columbia adds adalimumab to biosimilar...Biosimilars/General | Posted 16/04/2021
- Biosimilars in the treatment of psoriasisBiosimilars/Research | Posted 16/04/2021
- Advances for Formycon and Alteogen’s eye diseas...Biosimilars/News | Posted 16/04/2021